These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 25973022)
21. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease. Greene CL; Worrell SG; DeMeester TR Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684 [TBL] [Abstract][Full Text] [Related]
22. Regulation of CDX2 expression in esophageal adenocarcinoma. Vaninetti N; Williams L; Geldenhuys L; Porter GA; Guernsey DL; Casson AG Mol Carcinog; 2009 Oct; 48(10):965-74. PubMed ID: 19415720 [TBL] [Abstract][Full Text] [Related]
23. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Souza RF; Krishnan K; Spechler SJ Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417 [TBL] [Abstract][Full Text] [Related]
24. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia. Souza RF J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845 [TBL] [Abstract][Full Text] [Related]
25. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer. D'Onofrio V; Bovero E; Iaquinto G Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268 [TBL] [Abstract][Full Text] [Related]
27. Expression of CDX2 and MUC2 in Barrett's mucosa. Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110 [TBL] [Abstract][Full Text] [Related]
28. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma. Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942 [TBL] [Abstract][Full Text] [Related]
29. CDX2 hox gene product in a rat model of esophageal cancer. Ingravallo G; Dall'Olmo L; Segat D; Fassan M; Mescoli C; Dazzo E; Castoro C; Polimeno L; Rizzetto C; Baroni MD; Zaninotto G; Ancona E; Rugge M J Exp Clin Cancer Res; 2009 Aug; 28(1):108. PubMed ID: 19664209 [TBL] [Abstract][Full Text] [Related]
30. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma. Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568 [TBL] [Abstract][Full Text] [Related]
31. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model. Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117 [TBL] [Abstract][Full Text] [Related]
32. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux. Liu FX; Wang WH; Wang J; Li J; Gao PP Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415 [TBL] [Abstract][Full Text] [Related]
33. Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus. Castillo D; Puig S; Iglesias M; Seoane A; de Bolós C; Munitiz V; Parrilla P; Comerma L; Poulsom R; Krishnadath KK; Grande L; Pera M J Gastrointest Surg; 2012 Feb; 16(2):227-37; discussion 237. PubMed ID: 22076569 [TBL] [Abstract][Full Text] [Related]
34. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793 [TBL] [Abstract][Full Text] [Related]
35. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029 [TBL] [Abstract][Full Text] [Related]
36. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457 [TBL] [Abstract][Full Text] [Related]
37. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412 [TBL] [Abstract][Full Text] [Related]
38. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma. Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139 [TBL] [Abstract][Full Text] [Related]